Treatment of Clinically Isolated Syndrome (CIS) suggestive of MS with a DMD may delay the conversion to RRMS [1], and DMD treatment of RRMS may substantially decrease the risk of conversion to secondary progressive MS [2, 3]. Here, DMD is linked to myeloid sarcoma.